Method choice is crucial to when seeking answers to biosimilar characterization questions.
Guillaume Tremintin
Advertisement
Guillaume Tremintin is the biopharma market manager for Bruker Daltonics.
Articles by Guillaume Tremintin
Advertisement
Latest Updated Articles
Matching Tools to Biophysical Analysis DemandsJuly 1st 2017
Advertisement
Advertisement